XOMA Royalty Corp (XOMA) insider trading.
In Q3 2026, insiders at XOMA Royalty Corp reported 28 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 28
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 11
- Last filed
- 2026-07-16
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Sitko Bradley | Officer · Chief Investment Officer | 9 | 0 | 0 |
| BIOTECHNOLOGY VALUE FUND L P / BIOTECHNOLOGY VALUE FUND II LP / BVF GP HOLDINGS LLC / BVF II GP LLC / Biotechnology Value Trading Fund OS LP / BVF PARTNERS L P/IL / BVF INC/IL / LAMPERT MARK N / BVF Partners OS Ltd. / BVF I GP LLC | TenPercentOwner, Other | 4 | 0 | 0 |
| Hughes Owen | Director, Officer · Chief Executive Officer | 3 | 0 | 0 |
| Limber Joseph M | Director | 3 | 0 | 0 |
| Hernday Natasha | Director | 2 | 0 | 0 |
| Montano Maricel Perea | Officer · Chief Legal Officer | 2 | 0 | 0 |
| Franklin Heather L | Director | 1 | 0 | 0 |
| Trigilio Jeffrey | Officer · Chief Financial Officer | 1 | 0 | 0 |
| Perry Matthew D | Director | 1 | 0 | 0 |
| Wyszomierski Jack L | Director | 1 | 0 | 0 |
| Kosacz Barbara | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-14 | BIOTECHNOLOGY VALUE FUND L P / BIOTECHNOLOGY VALUE FUND II LP / BVF GP HOLDINGS LLC / BVF II GP LLC / Biotechnology Value Trading Fund OS LP / BVF PARTNERS L P/IL / BVF INC/IL / LAMPERT MARK N / BVF Partners OS Ltd. / BVF I GP LLC | U (D) | 412,000 | — | 0 | Form 4 |
| 2026-07-14 | BIOTECHNOLOGY VALUE FUND L P / BIOTECHNOLOGY VALUE FUND II LP / BVF GP HOLDINGS LLC / BVF II GP LLC / Biotechnology Value Trading Fund OS LP / BVF PARTNERS L P/IL / BVF INC/IL / LAMPERT MARK N / BVF Partners OS Ltd. / BVF I GP LLC | U (D) | 2,773,545 | — | 0 | Form 4 |
| 2026-07-14 | BIOTECHNOLOGY VALUE FUND L P / BIOTECHNOLOGY VALUE FUND II LP / BVF GP HOLDINGS LLC / BVF II GP LLC / Biotechnology Value Trading Fund OS LP / BVF PARTNERS L P/IL / BVF INC/IL / LAMPERT MARK N / BVF Partners OS Ltd. / BVF I GP LLC | U (D) | 3,635,758 | — | 0 | Form 4 |
| 2026-07-14 | BIOTECHNOLOGY VALUE FUND L P / BIOTECHNOLOGY VALUE FUND II LP / BVF GP HOLDINGS LLC / BVF II GP LLC / Biotechnology Value Trading Fund OS LP / BVF PARTNERS L P/IL / BVF INC/IL / LAMPERT MARK N / BVF Partners OS Ltd. / BVF I GP LLC | U (D) | 772,000 | — | 0 | Form 4 |
| 2026-07-14 | Franklin Heather L | J (D) | 6,269 | — | 0 | Form 4 |
| 2026-07-14 | Trigilio Jeffrey | J (D) | 103,906 | — | 0 | Form 4 |
| 2026-07-14 | Perry Matthew D | J (D) | 24,138 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | J (D) | 75 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | J (D) | 1,287 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | J (D) | 83,765 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | J (D) | 75 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | J (D) | 1,500 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | D (D) | 82 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | D (D) | 2,000 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | D (D) | 7,045 | — | 0 | Form 4 |
| 2026-07-14 | Sitko Bradley | D (D) | 313 | — | 0 | Form 4 |
| 2026-07-14 | Hernday Natasha | J (D) | 9,304 | — | 0 | Form 4 |
| 2026-07-14 | Hernday Natasha | D (D) | 4,000 | — | 0 | Form 4 |
| 2026-07-14 | Wyszomierski Jack L | J (D) | 21,828 | — | 0 | Form 4 |
| 2026-07-14 | Hughes Owen | D (D) | 102,000 | — | 0 | Form 4 |
| 2026-07-14 | Hughes Owen | J (D) | 191,264 | — | 0 | Form 4 |
| 2026-07-14 | Hughes Owen | J (D) | 752 | — | 0 | Form 4 |
| 2026-07-14 | Kosacz Barbara | J (D) | 6,269 | — | 0 | Form 4 |
| 2026-07-14 | Limber Joseph M | D (D) | 20,000 | — | 0 | Form 4 |
| 2026-07-14 | Limber Joseph M | D (D) | 10,000 | — | 0 | Form 4 |
| 2026-07-14 | Limber Joseph M | J (D) | 9,532 | — | 0 | Form 4 |
| 2026-07-14 | Montano Maricel Perea | J (D) | 42,306 | — | 0 | Form 4 |
| 2026-07-14 | Montano Maricel Perea | J (D) | 65 | — | 0 | Form 4 |
Transaction codes in this quarter
Get XOMA insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=791908&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · XOMA Royalty Corp on SEC.gov
Questions
Are insiders buying or selling XOMA Royalty Corp (XOMA)?
In Q3 2026, insiders at XOMA Royalty Corp reported 28 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these XOMA Royalty Corp insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/xoma.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.